Arbutus Biopharma Corporation (NASDAQ:ABUS) Q2 2023 Earnings Call Transcript August 3, 2023
Arbutus Biopharma Corporation misses on earnings expectations. Reported EPS is $-0.1 EPS, expectations were $0.12.
Operator: Good day, and thank you for standing by. Welcome to the Arbutus Biopharma Q2 Conference Call. [Operator Instructions] Please be advised that today’s conference is being recorded. I would now like to hand the conference over to your speaker today, Lisa Caperelli. Please go...
